Stay updated with breaking news from Gsk ln. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Intel is planning an IPO of Its programmable chip business, Novartis is set to complete generics division spinoff, and other news to start your day. ....
Swiss pharmaceutical maker Novartis plans to spin off its Sandoz generic drugs division starting Wednesday, to focus on its core drug R&D business. ....
By Ben Glickman GSK has received approval from the Food and Drug Administration for its treatment for myelofibrosis. The British pharmaceutical company said. ....
By Anthony O. Goriainoff GSK said Japan has accepted for review a supplementary new drug application for its Nucala (mepolizumab) product for the treatment. ....